João Siffert, M.D.

João Siffert, M.D.

Former President and Chief Executive OfficeratDesign Therapeutics· In proxies 2022–2023

Pay in FY2023-27% from the year before · Design Therapeutics stock -74.2% the same year

João Siffert, M.D. was paid $3.5M in FY2023 (Dec), down 27%. Design Therapeutics stock fell 74.2% that year.

Pay$100 in the stock at the end of FY21 → $12
Pay is from the Summary Compensation Table of each Design Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Design TherapeuticsPublic company · 4 yr
    • Former President and Chief Executive Officer2022 – Present · 4 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?